Research study Program year 2020 Source: CMS Open Payments

M15-925

ClinicalTrials.gov NCT03086343

Research payments

$2,816,185

744 payments

Through program year 2020, $2,816,185 in research payments was reported against M15-925, across 744 payments, paid by AbbVie, Inc..

Paid by: AbbVie, Inc.
ClinicalTrials.gov: NCT03086343

By program year

2 rows

Year	Kind	Amount	Payments
2020	Research	$802,610	337
2019	Research	$2,013,574	407

Breakdown

Who paid Research payments · program years 2019–2020

AbbVie, Inc. $2,816,185 744 payments

Who received the money Research payments · program years 2019–2020

Dynamed Clinical Research LP Organisation paid for research $300,124 34 payments
Arizona Arthritis and Rheumatology Associates Organisation paid for research $287,708 51 payments
Care Access Research LLC Organisation paid for research $154,476 34 payments
Bluegrass Community Research INC Organisation paid for research $132,434 22 payments
Clinical Research of West Florida, Inc. Organisation paid for research $130,721 13 payments
Clinvest Research Llc. Organisation paid for research $112,077 12 payments
Gcm Medical Group, Psc Organisation paid for research $110,953 19 payments
Arthur Snyder MD Pc Organisation paid for research $103,902 10 payments
Ochsner Clinic Foundation Teaching hospital · LA $95,252 24 payments
West Tennessee Research Institute PLLC Organisation paid for research $92,938 14 payments

Usually the institution or organisation running the study, not a person.

Records

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

Principal investigators named

10 shown

Named on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.

What you are looking at

Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.